Christopher M Cimarusti

This inventor holds 55 USPTO granted patents, primarily in Beta-Lactam Chemistry (CPC class 2603). Top assignee: E. R. Squibb Sons, Inc.. Active years: 1976-1993.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Christopher M Cimarusti. Retrieved from https://idiyas.com/inventor/christopher-m-cimarusti

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 55

% Patents Active = 100.0

Average Co-Inventor Count = 2.5

ph-index = 8

Forward Citations = 244(Granted Patents)

Forward Citations (Not Self Cited) = 228(Dec 10, 2025)

Inventors with similar research interests:

Location History:

Hamilton Square, NJ (US) (1978 - 1979)
Hamilton, NJ (US) (1976 - 1981)
Yardley, PA (US) (1984)
Pennington, NJ (US) (1983 - 1988)
Somerset, NJ (US) (1976 - 1990)
Millstone, NJ (US) (1993)

Company Filing History:

55 out of 1,624

E. R. Squibb Sons, Inc.

patents

Years Active: 1976-1993

Loading Chart...

Areas of Expertise:

Beta-Lactams

Azetidines

Steroidal Compounds

Chemical Processes

Stereochemistry

Hypotensive Agents

D-Homo Oxasteroids

Thio-Beta-Lactams

Indantetrol Derivatives

Sulfamated Amino Acids

Cyclopentano Pregnenes

Secopregnane Derivatives

55 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 5194604 - Process and intermediates for beta-lactams having (1993-03-16),

2. 4937355 - Process for preparing (trans)-4-substituted-dl-proline derivatives (1990-06-26),

3. 4912230 - Process for stereochemically inverting a hydroxy function of an ester by (1990-03-27),

4. 4775670 - 2-oxo-1-azetidinesulfonic acid salts (1988-10-04),

5. 4704457 - Process for the preparation of (3S)-3-[[[2-(protected (1987-11-03),

6. 4625022 - Process for preparing (s)-3-amino-2-oxo-1-azetidinesulfonic acid salts (1986-11-25),

7. 4529698 - Process for preparing a 2-oxo-1-azetidinesulfonic acid salt (1985-07-16),

8. 4483797 - (S)-3-Isocyanato-2-oxo-1-azetidinesulfonic acids (1984-11-20),

9. 4478749 - 2-Oxo-1-(substituted phosphorous)azetidines (1984-10-23),

10. 4474702 - [16,17-a]Cyclopentano pregnenes (1984-10-02),

11. 4443374 - Process for preparing (1984-04-17),

12. 4421686 - 4-Norbornyl-sulfonyl azetidinone intermediates and process for preparing (1983-12-20),

13. 4386034 - Sulfamated amino acid amides (1983-05-31),

14. 4267373 - 5,6,7,8-Tetrahydronaphthalene hypotensive agents (1981-05-12),

15. 4252973 - Process for chemically removing the acyl sidechain from cephalosporins (1981-02-24),

Title: Christopher M Cimarusti: Innovator in Beta-Lactam Chemistry

Introduction

Christopher M Cimarusti is a prominent inventor based in Hamilton, NJ (US). He has made significant contributions to the field of chemistry, particularly in the development of beta-lactam compounds. With a total of 55 patents to his name, Cimarusti's work has had a substantial impact on pharmaceutical research and development.

Latest Patents

Cimarusti's latest patents include innovative processes for preparing beta-lactam compounds. One notable patent details a method for preparing a compound through the reaction of a novel compound with a beta-lactam, utilizing a base treatment. Another significant patent outlines a process for synthesizing (trans)-4-substituted-DL-proline derivatives, which are essential in the creation of angiotensin-converting enzyme inhibitors. This process involves reacting specific esters with a potassium amide base under controlled temperatures, followed by hydrolysis and the removal of protecting groups.

Career Highlights

Cimarusti has built a successful career at E. R. Squibb Sons, Inc., where he has been instrumental in advancing research in pharmaceutical chemistry. His expertise in beta-lactam synthesis has positioned him as a key figure in the industry, contributing to the development of important therapeutic agents.

Collaborations

Throughout his career, Cimarusti has collaborated with notable colleagues, including Frederic P Hauck and Ravi K Varma. These partnerships have fostered innovation and have led to the successful development of various pharmaceutical processes.

Conclusion

Christopher M Cimarusti is a distinguished inventor whose work in beta-lactam chemistry has significantly influenced the pharmaceutical industry. His numerous patents and collaborations highlight his commitment to advancing scientific knowledge and improving healthcare solutions.

Profile summary based on public USPTO records.

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]